10 February, 2014
Fredrik Henckel, who has served as the company’s CFO since September 2013 has been appointed new CEO.Fredrik Henckel before joining Chordate Medical most recently served as CEO of XCounter AB (publ), a company developing and selling X-ray detectors for medical, dental and industrial uses. XCounter was listed on NASDAQ OMX First North during his tenure. He has extensive past experience as CFO in multiple organisations.
Current CEO Fredrik Juto will become Executive Chairman following a re-organization of the Chordate Group.
If you want to read our press releases, there are available in the Investor Relations section or by clicking the link below.
For questions about Chordate's share price or other investment-related topics, please see if the answer is here.
For questions about the medical effects of the K.O.S treatment, please see if the answer is here.
To get in touch with Chordate regarding other questions, use the adjecent form. We do our best to respond as quickly as possible.